GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
2,524.85
+24.15 (0.97%)
At close: Nov 6, 2026
GlaxoSmithKline Pharmaceuticals Employees
GlaxoSmithKline Pharmaceuticals had 3,103 employees as of March 31, 2026. The number of employees decreased by 10 or 0.32% compared to the previous year. That makes GlaxoSmithKline Pharmaceuticals the 7,770th largest employer in the world and 513th in India.
Employees
3,103
Change (1Y)
-10
Growth (1Y)
-0.32%
Revenue / Employee
13.53M INR
Profits / Employee
3.69M INR
Market Cap
427.72B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 3,103 | -10 | -0.32% |
| Mar 31, 2025 | 3,113 | -98 | -3.05% |
| Mar 31, 2024 | 3,211 | -469 | -12.74% |
| Mar 31, 2023 | 3,680 | -160 | -4.17% |
| Mar 31, 2022 | 3,840 | -443 | -10.34% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Lupin | 26,021 |
| Torrent Pharmaceuticals | 18,258 |
| Jubilant Pharmova | 5,657 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Granules India | 4,306 |
| Caplin Point Laboratories | 4,199 |
| Abbott India | 3,679 |
GlaxoSmithKline Pharmaceuticals News
- 3 days ago - GlaxoSmithKline Pharmaceuticals Transcript: Q2 26/27 - Transcripts
- 3 days ago - GlaxoSmithKline Pharmaceuticals Quarterly report: Q2 2027 - Filings
- 3 days ago - GlaxoSmithKline Pharmaceuticals Slides: Q2 2027 - Filings
- 3 months ago - GlaxoSmithKline Pharmaceuticals Transcript: Q1 26/27 - Transcripts
- 3 months ago - GlaxoSmithKline Pharmaceuticals Slides: Q1 2027 - Filings
- 3 months ago - GlaxoSmithKline Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 5 months ago - GlaxoSmithKline Pharmaceuticals Transcript: Q4 25/26 - Transcripts
- 5 months ago - GlaxoSmithKline Pharmaceuticals Quarterly report: Q4 2026 - Filings